division of infectious diseases

December 8, 2023

You missed a few: a better way to count health care-associated influenza cases

The traditional definition of health care-associated influenza leads to gross undercounting, a Vanderbilt study suggests.

By Paul Govern
November 16, 2023

Nasty microbe H. pylori has Achilles’ heel

Vanderbilt researchers found that an H. pylori enzyme is essential for colonization of the stomach, suggesting it as a promising therapeutic target for H. pylori infection.

By Paul Govern
May 8, 2023

Harris named Department of Medicine’s executive vice chair for Clinical Affairs

Bryan Harris, MD, MPH, MMHC, has been named executive vice chair for Clinical Affairs for Vanderbilt’s Department of Medicine, effective July 1.

By Jill Clendening
April 25, 2023

COVID alters respiratory microbiota

COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions.

By Leigh MacMillan
March 9, 2023

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

By Bill Snyder
February 6, 2023

Gut microbiota and lung fibrosis

Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.

By Leigh MacMillan
February 2, 2023

COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.
By Sarah E. Glass
January 26, 2023

Study to explore COVID’s impact on essential workers

Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.
By Jill Clendening
January 19, 2023

Emerging Infections Program lands national award for COVID response

Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.
By Jake Lowary
December 21, 2022

Flu season came early, hit hard in Tennessee

Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center.
By Craig Boerner
December 15, 2022

Dooley honored by Treatment Action Group

Vanderbilt's Kelly Dooley, MD, PhD, MPH, recently received the Research in Action Award from the Treatment Action Group (TAG).
By Paul Govern
July 7, 2022

Breaking the stigma of AIDS part of Raffanti’s long legacy

On June 29 Stephen Raffanti, MD, MPH, hung up his scrubs at the Vanderbilt Comprehensive Care Clinic for the last time. It was a bittersweet moment for the man who helped lead Nashville out of the darkest days of the AIDS epidemic 30 years ago.
By Bill Snyder
June 16, 2022

VUMC to pilot CDC joint training program

Vanderbilt University Medical Center is among 11 centers that will pilot a new federally sponsored training program, the Joint Infectious Diseases/Epidemic Intelligence Service (ID/EIS) Fellowship.
By Paul Govern
1 2 3 … 5